Phase 3 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a type of blood cancer called peripheral T-cell lymphoma (PTCL), including certain NK/T-cell lymphomas, but not the type that tests positive for a protein called ALK — and whose cancer responded to their first round of treatment (either completely or partially).
- People whose kidneys are working well enough to meet specific function levels, as measured by blood and urine tests (confirm with trial site for exact values).
- People whose liver is functioning within acceptable ranges, based on standard blood tests.
- People whose lungs are working at 50% or more of the expected level for their age and size.
- People whose heart is pumping well (left ventricle ejection fraction of at least 50%) and who have no symptoms from any irregular heartbeat.
- People aged between 18 and 65 years old, of any gender.
- People who are generally well enough to carry out daily activities, rated 0 or 1 on a standard medical fitness scale (ECOG scale).
- People whose blood cell counts and stem cell levels meet specific minimum thresholds, as measured by blood tests (confirm with trial site for exact values).
- People whose life expectancy is at least 3 months.
- People who are willing and able to sign a written consent form agreeing to take part.
Who may not be able to join:
- People whose lymphoma has spread to the brain or spinal cord.
- People with an active hepatitis B or hepatitis C infection.
- People who currently have an active infection of any kind.
- People living with HIV.
- People who have cirrhosis or scarring of the liver.
- People whose heart tracing (ECG) shows a specific type of irregular reading (QTc interval greater than 500ms).
- People who have a mental disability or are otherwise unable to give informed consent.
- People with a history of drug or alcohol misuse that could affect the study results.
- Women who are pregnant, breastfeeding, or of childbearing age who are unwilling to use contraception during the trial.
- People whom the trial researchers determine are not suitable to participate, for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: wei xu, : China, Jiangsu Hematological Department, People's Hospital of Jiangsu Province
Phone: 86-25-68302182
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
2-y PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.